Crossmark

Dosage adjustments in pivotal clinical trials with oral targeted therapies in solid tumors conducted in Europe

Crossref DOI link: https://doi.org/10.1007/s00228-018-02621-w

Published Online: 2019-01-08

Published Print: 2019-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lasala, Ruggero

Santoleri, Fiorenzo

Romagnoli, Alessia

Musicco, Felice

Costantini, Alberto
License Information

Text and Data Mining valid from 2019-01-08
More Information

Article History

Received: 25 October 2018

Accepted: 26 December 2018

First Online: 8 January 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.